{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:09:08Z","timestamp":1789384148028,"version":"build-2803163510"},"reference-count":40,"publisher":"European Respiratory Society (ERS)","issue":"6","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL138190"],"award-info":[{"award-number":["K23HL138190"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL146942"],"award-info":[{"award-number":["K23HL146942"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL148498"],"award-info":[{"award-number":["K23HL148498"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2020,6,28]]},"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>Interstitial pneumonia with autoimmune features (IPAF) characterises individuals with interstitial lung disease (ILD) and features of connective tissue disease (CTD) who fail to satisfy CTD criteria. Inclusion of myositis-specific antibodies (MSAs) in the IPAF criteria has generated controversy, as these patients also meet proposed criteria for an antisynthetase syndrome. Whether MSAs and myositis-associated antibodies (MAA) identify phenotypically distinct IPAF subgroups remains unclear.<\/jats:p><jats:p>A multicentre, retrospective investigation was conducted to assess clinical features and outcomes in patients meeting IPAF criteria stratified by the presence of MSAs and MAAs. IPAF subgroups were compared to cohorts of patients with idiopathic inflammatory myopathy-ILD (IIM-ILD), idiopathic pulmonary fibrosis and non-IIM CTD-ILDs. The primary end-point assessed was 3-year transplant-free survival.<\/jats:p><jats:p>269 patients met IPAF criteria, including 35 (13%) with MSAs and 65 (24.2%) with MAAs. Survival was highest among patients with IPAF-MSA and closely approximated those with IIM-ILD. Survival did not differ between IPAF-MAA and IPAF without MSA\/MAA cohorts. Usual interstitial pneumonia (UIP) morphology was associated with differential outcome risk, with IPAF patients with non-UIP morphology approximating survival observed in non-IIM CTD-ILDs. MSAs, but not MAAs identified a unique IPAF phenotype characterised by clinical features and outcomes similar to IIM-ILD. UIP morphology was a strong predictor of outcome in others meeting IPAF criteria.<\/jats:p><jats:p>Because IPAF is a research classification without clear treatment approach, these findings suggest that MSAs should be removed from the IPAF criteria and such patients should be managed as an IIM-ILD.<\/jats:p>","DOI":"10.1183\/13993003.01205-2020","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T20:44:44Z","timestamp":1594932284000},"page":"2001205","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype"],"prefix":"10.1183","volume":"56","author":[{"given":"Julia","family":"Graham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iazsmin","family":"Bauer Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad A.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Boctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Vu Pugashetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Cutting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Joerns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habrinder","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Kim","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kadoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Noth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodeji","family":"Adegunsoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Strek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M.","family":"Oldham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"2024102101510257000_56.6.2001205.1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00101506"},{"key":"2024102101510257000_56.6.2001205.2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/resp.12588","article-title":"Idiopathic interstitial pneumonias with connective tissue diseases features: a review","volume":"21","author":"Cottin","year":"2016","journal-title":"Respirology"},{"key":"2024102101510257000_56.6.2001205.3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0194"},{"key":"2024102101510257000_56.6.2001205.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00150-2015"},{"key":"2024102101510257000_56.6.2001205.5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rmed.2016.10.017","article-title":"Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients","volume":"123","author":"Ahmad","year":"2017","journal-title":"Respir Med"},{"key":"2024102101510257000_56.6.2001205.6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.201907-1343LE","article-title":"Circulating plasma biomarkers of progressive interstitial lung disease","volume":"201","author":"Alqalyoobi","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101510257000_56.6.2001205.7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.rmed.2017.07.015","article-title":"Longitudinal assessment of interstitial pneumonia with autoimmune features is encouraged","volume":"132","author":"Chartrand","year":"2017","journal-title":"Respir Med"},{"key":"2024102101510257000_56.6.2001205.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01641-2018"},{"key":"2024102101510257000_56.6.2001205.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01565-2015"},{"key":"2024102101510257000_56.6.2001205.10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12890-017-0453-z","article-title":"Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features","volume":"17","author":"Ito","year":"2017","journal-title":"BMC Pulm Med"},{"key":"2024102101510257000_56.6.2001205.11","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.00002015"},{"key":"2024102101510257000_56.6.2001205.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01259-2016"},{"key":"2024102101510257000_56.6.2001205.13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.chest.2018.08.1074","article-title":"Point: does interstitial pneumonia with autoimmune features represent a distinct class of patients with idiopathic interstitial pneumonia? Yes","volume":"155","author":"Lee","year":"2019","journal-title":"Chest"},{"key":"2024102101510257000_56.6.2001205.14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chest.2018.08.1073","article-title":"Counterpoint: does interstitial pneumonia with autoimmune features represent a distinct class of patients with idiopathic interstitial pneumonia? No","volume":"155","author":"Oldham","year":"2019","journal-title":"Chest"},{"key":"2024102101510257000_56.6.2001205.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01841-2016"},{"key":"2024102101510257000_56.6.2001205.16","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0180"},{"key":"2024102101510257000_56.6.2001205.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2024102101510257000_56.6.2001205.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2024102101510257000_56.6.2001205.19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468"},{"key":"2024102101510257000_56.6.2001205.20","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1474"},{"key":"2024102101510257000_56.6.2001205.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2024102101510257000_56.6.2001205.22","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121043"},{"key":"2024102101510257000_56.6.2001205.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.08.015"},{"key":"2024102101510257000_56.6.2001205.24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.rmed.2016.11.007","article-title":"Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease","volume":"121","author":"Oldham","year":"2016","journal-title":"Respir Med"},{"key":"2024102101510257000_56.6.2001205.25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200607-912OC"},{"key":"2024102101510257000_56.6.2001205.26","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024102101510257000_56.6.2001205.27","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00174910"},{"key":"2024102101510257000_56.6.2001205.28","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2662"},{"key":"2024102101510257000_56.6.2001205.29","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/art.40679","article-title":"Interstitial pneumonia with autoimmune features: an emerging challenge at the intersection of rheumatology and pulmonology","volume":"70","author":"Wilfong","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2024102101510257000_56.6.2001205.30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215515"},{"key":"2024102101510257000_56.6.2001205.31","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/rheumatology\/key451","article-title":"Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis","volume":"58","author":"Infantino","year":"2019","journal-title":"Rheumatology"},{"key":"2024102101510257000_56.6.2001205.32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213153"},{"key":"2024102101510257000_56.6.2001205.33","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212915"},{"key":"2024102101510257000_56.6.2001205.34","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.chest.2019.05.023","article-title":"Long-term treatment with azathioprine and mycophenolate mofetil for myositis-related interstitial lung disease","volume":"156","author":"Huapaya","year":"2019","journal-title":"Chest"},{"key":"2024102101510257000_56.6.2001205.35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.rmed.2017.03.028","article-title":"Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies","volume":"132","author":"Scir\u00e8","year":"2017","journal-title":"Respir Med"},{"key":"2024102101510257000_56.6.2001205.36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12931-019-1231-7","article-title":"Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody","volume":"20","author":"Sclafani","year":"2019","journal-title":"Respir Res"},{"key":"2024102101510257000_56.6.2001205.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113354"},{"key":"2024102101510257000_56.6.2001205.38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1164\/rccm.201809-1646OC","article-title":"Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis","volume":"200","author":"Newton","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101510257000_56.6.2001205.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.09.002"},{"key":"2024102101510257000_56.6.2001205.40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.rmed.2019.03.011","article-title":"Clinical, serological and radiological features of a prospective cohort of interstitial pneumonia with autoimmune features (IPAF) patients","volume":"150","author":"Sambataro","year":"2019","journal-title":"Respir Med"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01205-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:35:33Z","timestamp":1740382533000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01205-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,12,3]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1183\/13993003.01205-2020"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01205-2020","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]}}}